Veracyte, Inc. , a leading cancer diagnostics company, today announced that its TrueMRD Monitoring Test has received coverage from the Centers for Medicare & Medicaid Services' (CMS) Molecular ...

Medicare beneficiaries enrolled in Part D plans offered by vertically integrated insurers paid lower monthly premiums but higher out-of-pocket drug costs compared to enrollees in other plans, ...

Even though people 65 and older have Medicare, they still face considerable healthcare costs. The 10% increase in Medicare Part B premiums for 2026 has reignited concerns about how much in Social ...

This study evaluated differences in racial and ethnic disparities in surgical outcomes between Medicare Advantage and traditional Medicare beneficiaries, finding consistent but nonuniform smaller ...

Two of the largest Medicare Advantage fraud settlements ever announced landed in the first quarter of 2026. One was $556 million in January, the largest risk-adjustment recovery ...

Women are less likely to stay on TNF and IL-17 inhibitors compared with men, according to findings of a new study.

While available data on premium payments is mainly from January, a few states that run their own ACA markets have released ...

Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the ...

Pro forma operating loss -- $7.9 million, widened from a pro forma operating loss of $4.7 million in the prior year; ...

Sneak peek at upcoming San Diego-area street fairs, festivals, concerts, performances, art shows, library events, community ...

Cancer diagnostics company Pacific Edge (NZX/ASX: PEB) today notes that a draft Local Coverage Determination (LCD) with foundational medical policy for urine-based biomarkers for hematuria evaluation ...